Pharmaceutical Industry Information Portal

HomeWorld Pharma News

World Pharma News

Moderna, IAVI – new collaboration on the use of mRNA technology

Moderna, Inc. and the nonprofit scientific research organization IAVI, on April 7th, announced a new collaboration to employ mRNA technology to meet the challenge...

Jazz’s first immuno-oncology program in the company’s portfolio

Jazz Pharmaceuticals plc and Werewolf Therapeutics, Inc. On Thursday announced that the companies have entered into a licensing agreement under which Jazz has acquired...

FDA Approves alpelisib as first and only treatment for PROS, a spectrum of rare conditions

Novartis on Wednesday announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and...

Pfizer expands RSV portfolio by acquiring ReViral for up to $525 million

Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...

Sandoz, Ares Genetics expand digital alliance in antimicrobial resistance

Sandoz announces the extension and expansion of its strategic collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global...

Bioxcell Therapeutics announces FDA approval of IGALMI, the first new acute treatment for schizophrenia or bipolar disorder

BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop transformative medicines in neuroscience and immuno-oncology, on Wednesday announced...
spot_img

Expert Articles

spot_img